Altimmune Inc
NASDAQ:ALT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Altimmune Inc
NASDAQ:ALT
|
US |
|
Abundance International Ltd
SGX:541
|
SG |
|
Asmallworld AG
F:1Q7
|
CH |
|
MedCap AB (publ)
STO:MCAP
|
SE |
|
S
|
Shin-Etsu Chemical Co Ltd
OTC:SHECY
|
JP |
|
A
|
Apex Critical Metals Corp
OTC:APXCF
|
CA |
|
Toray Industries Inc
TSE:3402
|
JP |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
|
Wizz Air Holdings PLC
LSE:WIZZ
|
HU |
|
E
|
Eckert & Ziegler SE
F:EUZ
|
DE |
|
NatWest Group PLC
F:RYSD
|
UK |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
Italmobiliare SpA
MIL:ITM
|
IT |
|
E
|
Eckert & Ziegler SE
XMUN:EUZ
|
DE |
|
S
|
Sabre Resources Ltd
F:SAL
|
AU |
|
O
|
Oculis Holding AG
ICEX:OCS
|
CH |
|
AMTD IDEA Group
F:9AM1
|
FR |
|
H
|
Hyundai Motor Co
KRX:005389
|
KR |
|
Astellas Pharma Inc
F:YPH
|
JP |
|
J
|
JcbNext Bhd
KLSE:JCBNEXT
|
MY |
|
W
|
WPP PLC
DUS:0WP
|
UK |
|
P
|
Prosperity Bancshares, Inc
F:PPY
|
US |
|
B
|
Bumi Resources Minerals Tbk PT
SWB:BUR
|
ID |
|
NatWest Group PLC
F:RYS
|
UK |
Bankruptcy Probability
Altimmune Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Altimmune Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Altimmune Inc
NASDAQ:ALT
|
396.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Altimmune Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Altimmune Inc has total debt of 34.7m USD. This includes both short-term (0 USD) and long-term (34.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
